Vitamin D and p53—differentiating their relationship in AML.
Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA.
Orla
O
Maguire
Moray J
MJ
Campbell
D000975:Antioxidants / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D002117:Calcitriol / Q000494:pharmacology*; D004249:DNA Damage; D004260:DNA Repair; D016193:G1 Phase / Q000187:drug effects*; D016158:Genes, p53; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D009154:Mutation; D011379:Prognosis; D016196:S Phase / Q000187:drug effects; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
D000975:Antioxidants; D016159:Tumor Suppressor Protein p53; D002117:Calcitriol